These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8427981)

  • 1. Plasma cell acid phosphatase in multiple myeloma.
    Musto P
    Blood; 1993 Feb; 81(3):869-70. PubMed ID: 8427981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease].
    Strippoli S; Stucci S; Dammacco F; Silvestris F
    Recenti Prog Med; 2011 Feb; 102(2):88-95. PubMed ID: 21513124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell acid phosphatase score in multiple myeloma and related disorders.
    Hoffmann JJ; Breed WP; Swaak-Lammers N
    Br J Haematol; 1985 Jan; 59(1):67-72. PubMed ID: 3970852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytochemistry of plasma cells (author's transl)].
    Miliani A; Anichini P; Pellegrini G; Firorelli C; Cozzolino F
    Haematologica; 1979 Oct; 64 Suppl():35-9. PubMed ID: 161540
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma cell acid phosphatase and prognosis in multiple myeloma.
    Musto P; Fusilli S; Carotenuto M
    Leuk Lymphoma; 1994 Aug; 14(5-6):497-501. PubMed ID: 7812211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological and clinical significance of plasma-cell acid phosphatase in multiple myeloma].
    Musto P; Barbieri D; Gennari M; Spanedda R; Scapoli G; Carotenuto M; Castoldi G
    Recenti Prog Med; 1986 Oct; 77(10):452-60. PubMed ID: 3823590
    [No Abstract]   [Full Text] [Related]  

  • 7. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
    Cassuto JP; Hammou JC; Pastorelli E; Dujardin P; Masseyeff R
    Biomedicine; 1977 Jul; 27(5):197-9. PubMed ID: 922119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative cytochemical study of some enzymatic activities in normal and myelomatous plasma cells (author's transl)].
    Invernizzi R; Ippoliti G; Cattaneo G; Trpin L; Casirola G; Carnevale-Maffé G; Cordani M
    Haematologica; 1979 Dec; 64(6):726-34. PubMed ID: 161879
    [No Abstract]   [Full Text] [Related]  

  • 11. Behaviour of leukocyte acid phosphatase in various chronic diseases.
    Micu D; Mihăilescu E; Cheţa D; Olinescu V; Pop A
    Med Interne; 1976; 14(2):103-7. PubMed ID: 1071475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vacuolated plasma cells in multiple myeloma.
    Kanoh T; Yasuda N; Takamatsu T; Uchino H
    Tohoku J Exp Med; 1986 Apr; 148(4):361-4. PubMed ID: 3526637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and electron microscopic studies in lymphoid plasmacellular reticulosis].
    Pietschmann H; Stockinger L
    Blut; 1970 Feb; 20(2):76-85. PubMed ID: 4245216
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
    Saeed SM; Stock-Novack D; Pohlod R; Crowley J; Salmon SE
    Blood; 1991 Dec; 78(12):3281-7. PubMed ID: 1742488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical study on plasma cells.
    Suzuki A; Shibata A; Onodera S; Miura AB; Sakamoto S
    Tohoku J Exp Med; 1969 Jan; 97(1):1-9. PubMed ID: 4306171
    [No Abstract]   [Full Text] [Related]  

  • 16. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias.
    Tortarolo M; Cantore N; Grande M; Buonanno G; Dammacco F
    Acta Haematol; 1981; 65(2):103-7. PubMed ID: 6785954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.
    Monti M; Scazzoso A; Calzaferri G; Santi I; D'Aprile E; Cunietti E
    Int J Biol Markers; 1990; 5(2):61-4. PubMed ID: 2283478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
    Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
    J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients.
    Bataille R; Durie BG; Sany J; Salmon SE
    Blood; 1980 May; 55(5):802-5. PubMed ID: 6767509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.